JPS54135769A - Novel mercaptoimidazole derivative*its manufacture and pharmateutical medicine containing it and its application - Google Patents
Novel mercaptoimidazole derivative*its manufacture and pharmateutical medicine containing it and its applicationInfo
- Publication number
- JPS54135769A JPS54135769A JP4311779A JP4311779A JPS54135769A JP S54135769 A JPS54135769 A JP S54135769A JP 4311779 A JP4311779 A JP 4311779A JP 4311779 A JP4311779 A JP 4311779A JP S54135769 A JPS54135769 A JP S54135769A
- Authority
- JP
- Japan
- Prior art keywords
- pharmateutical
- novel
- manufacture
- application
- medicine containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU79412 | 1978-04-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS54135769A true JPS54135769A (en) | 1979-10-22 |
| JPS6339594B2 JPS6339594B2 (ja) | 1988-08-05 |
Family
ID=19728887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4311779A Granted JPS54135769A (en) | 1978-04-11 | 1979-04-11 | Novel mercaptoimidazole derivative*its manufacture and pharmateutical medicine containing it and its application |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US4461770A (ja) |
| EP (1) | EP0004648B1 (ja) |
| JP (1) | JPS54135769A (ja) |
| KR (2) | KR820002314B1 (ja) |
| AT (1) | AT376971B (ja) |
| AU (1) | AU532402B2 (ja) |
| CS (1) | CS220324B2 (ja) |
| CY (1) | CY1302A (ja) |
| DD (1) | DD142712A5 (ja) |
| DE (1) | DE2963572D1 (ja) |
| DK (1) | DK148879A (ja) |
| ES (5) | ES479490A0 (ja) |
| FI (1) | FI65066C (ja) |
| GR (1) | GR71193B (ja) |
| HK (1) | HK87285A (ja) |
| HU (1) | HU182018B (ja) |
| IL (1) | IL57040A (ja) |
| MY (1) | MY8600271A (ja) |
| NO (1) | NO148926C (ja) |
| NZ (1) | NZ190153A (ja) |
| PL (2) | PL125882B1 (ja) |
| PT (1) | PT69460A (ja) |
| SU (2) | SU1259962A3 (ja) |
| ZA (1) | ZA791702B (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005539035A (ja) * | 2002-08-20 | 2005-12-22 | メルクル・ゲーエムベーハー | ２−チオ置換イミダゾール誘導体および製薬におけるその使用 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2823197A1 (de) * | 1978-05-24 | 1979-11-29 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE2856909A1 (de) * | 1978-12-28 | 1980-07-17 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE3025484A1 (de) * | 1980-07-03 | 1982-02-04 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| US4686231A (en) * | 1985-12-12 | 1987-08-11 | Smithkline Beckman Corporation | Inhibition of 5-lipoxygenase products |
| US4780470A (en) * | 1986-08-19 | 1988-10-25 | Smithkline Beckman Corporation | Inhibition of interleukin-1 by monocytes and/or macrophages |
| FI91754C (fi) * | 1986-12-02 | 1994-08-10 | Tanabe Seiyaku Co | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi |
| US5955480A (en) * | 1996-11-20 | 1999-09-21 | Merck & Co., Inc. | Triaryl substituted imidazoles, compositions containing such compounds and methods of use |
| US5965583A (en) * | 1997-04-24 | 1999-10-12 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted imidazoles useful in the treatment of inflammatory disease |
| KR20010014288A (ko) * | 1997-06-30 | 2001-02-26 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 염증성 질환의 치료에 유용한 2-치환된 이미다졸 |
| DE19842833B4 (de) * | 1998-09-18 | 2005-04-14 | Merckle Gmbh | 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung |
| DE10107683A1 (de) * | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| US8134029B2 (en) | 2002-09-16 | 2012-03-13 | Sunovion Pharmaceuticals Inc. | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
| CA2614282A1 (en) | 2005-07-06 | 2007-01-11 | Sepracor Inc. | Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
| PT2816024T (pt) | 2006-03-31 | 2017-10-20 | Sunovion Pharmaceuticals Inc | Aminas quirais |
| EP1894925A1 (en) * | 2006-08-24 | 2008-03-05 | Merckle Gmbh | Imidazole compounds having an antiinflammatory effect |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2981739A (en) * | 1958-01-27 | 1961-04-25 | Diamond Alkali Co | Certain alpha-haloaldehyde addition products of ethylenethioureas and process |
| US3714179A (en) * | 1970-09-08 | 1973-01-30 | Searle & Co | 1-alkyl-2-furfurylthioimidazoles and congeners |
| JPS5343958B2 (ja) * | 1972-07-29 | 1978-11-24 | ||
| SE428686B (sv) * | 1975-08-11 | 1983-07-18 | Du Pont | Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler |
| DK16778A (da) * | 1977-02-09 | 1978-08-10 | Du Pont | Imidazolderivater deres anvendelser og fremstilling |
| US4159338A (en) * | 1977-02-09 | 1979-06-26 | E. I. Du Pont De Nemours And Company | Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones |
| LU77703A1 (de) * | 1977-07-07 | 1979-03-26 | Ciba Geigy Ag | Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen |
| DE2823197A1 (de) * | 1978-05-24 | 1979-11-29 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| US4308277A (en) * | 1978-08-10 | 1981-12-29 | Ciba-Geigy Corporation | 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions containing same |
| US4175127A (en) * | 1978-09-27 | 1979-11-20 | Smithkline Corporation | Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles |
| DE2856909A1 (de) * | 1978-12-28 | 1980-07-17 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
-
1979
- 1979-03-30 DE DE7979100962T patent/DE2963572D1/de not_active Expired
- 1979-03-30 CY CY1302A patent/CY1302A/xx unknown
- 1979-03-30 EP EP79100962A patent/EP0004648B1/de not_active Expired
- 1979-04-06 PL PL1979226123A patent/PL125882B1/pl unknown
- 1979-04-06 PL PL1979214745A patent/PL125972B1/pl unknown
- 1979-04-06 GR GR58824A patent/GR71193B/el unknown
- 1979-04-09 DD DD79212098A patent/DD142712A5/de unknown
- 1979-04-09 FI FI791158A patent/FI65066C/fi not_active IP Right Cessation
- 1979-04-10 KR KR7901118A patent/KR820002314B1/ko active
- 1979-04-10 AT AT0266179A patent/AT376971B/de not_active IP Right Cessation
- 1979-04-10 IL IL57040A patent/IL57040A/xx unknown
- 1979-04-10 SU SU2747651A patent/SU1259962A3/ru active
- 1979-04-10 CS CS792438A patent/CS220324B2/cs unknown
- 1979-04-10 ZA ZA791702A patent/ZA791702B/xx unknown
- 1979-04-10 DK DK148879A patent/DK148879A/da not_active IP Right Cessation
- 1979-04-10 AU AU45994/79A patent/AU532402B2/en not_active Ceased
- 1979-04-10 ES ES479490A patent/ES479490A0/es active Granted
- 1979-04-10 NO NO791228A patent/NO148926C/no unknown
- 1979-04-10 HU HU79CI1925A patent/HU182018B/hu unknown
- 1979-04-10 NZ NZ190153A patent/NZ190153A/en unknown
- 1979-04-10 PT PT69460A patent/PT69460A/pt unknown
- 1979-04-11 JP JP4311779A patent/JPS54135769A/ja active Granted
-
1980
- 1980-05-23 SU SU802925099A patent/SU991945A3/ru active
-
1981
- 1981-11-16 US US06/321,840 patent/US4461770A/en not_active Expired - Fee Related
-
1982
- 1982-09-16 ES ES515766A patent/ES8403877A1/es not_active Expired
- 1982-10-04 KR KR8204468A patent/KR820002315B1/ko active
-
1983
- 1983-12-30 ES ES528580A patent/ES528580A0/es active Granted
- 1983-12-30 ES ES528579A patent/ES528579A0/es active Granted
- 1983-12-30 ES ES528581A patent/ES528581A0/es active Granted
-
1984
- 1984-03-09 US US06/588,024 patent/US4584310A/en not_active Expired - Fee Related
- 1984-03-09 US US06/588,025 patent/US4608382A/en not_active Expired - Fee Related
-
1985
- 1985-11-07 HK HK872/85A patent/HK87285A/xx unknown
-
1986
- 1986-12-30 MY MY271/86A patent/MY8600271A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005539035A (ja) * | 2002-08-20 | 2005-12-22 | メルクル・ゲーエムベーハー | ２−チオ置換イミダゾール誘導体および製薬におけるその使用 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS54145645A (en) | *mmbenzoyllphenoxy**22propionic acid derivative and medicine | |
| JPS55147223A (en) | Pharmaceutical medicine | |
| JPS54135769A (en) | Novel mercaptoimidazole derivative*its manufacture and pharmateutical medicine containing it and its application | |
| JPS55115866A (en) | Allicinncyclodextrin contained complex and medicine | |
| JPS55113715A (en) | Propanone derivatives and medicine containing them | |
| JPS54157570A (en) | Nnoxacycliccalkylpiperizylldiaza compounds* these manufactures and medicine containing them | |
| JPS54157565A (en) | 55nitroimidazole derivative*its manufacture and use | |
| JPS5517382A (en) | Nnarylsulfonylpyrrole*its manufacture and medicine containing it | |
| JPS554365A (en) | Cyclohexane derivative*its manufacture and medicine containing it | |
| JPS5533467A (en) | 11phenyll11propanol derivative*its manufacture and medicine containing it | |
| JPS54128555A (en) | Nnphenylalanine derivative*its manufacture and medicine | |
| DE2966178D1 (en) | Compounds of the muramyl-peptide type and medicines containing them | |
| JPS5517385A (en) | Benzimidazolinone derivative and medical composition containing it | |
| JPS54130562A (en) | Photoactive benzamide*its manufacture and medicine containing it | |
| JPS54138116A (en) | Medical constituent of mannentake | |
| JPS54130586A (en) | 55fluorouracil derivative*its manufacture and drug containing it | |
| JPS5555155A (en) | 66methoxyy22acetylnaphthaleneoxime derivative*its manufacture and medical composition | |
| JPS552698A (en) | Thienooor furopyridone derivative* its manufacture and therapeutic composition containing it | |
| JPS54151992A (en) | Alkoxycarbonyll33benzodiazepin novel derivatives*their manufacture and medicine containing them | |
| JPS54100366A (en) | 33aminorpopoxy aryl derivative*its manufacture and use | |
| JPS54154767A (en) | 55arylaminoo2*22difluoroodibenzodioxol*its manufacture and its use for vermine expelling | |
| JPS5535095A (en) | Novel 22bromoergosinine*its manufacture and medicine containing it | |
| JPS5572172A (en) | Diastereomerr11*44chlorophenoxy**11 *11imidazolyl**3*33dimethyll22butanol*its manufacture and use as drug | |
| JPS5533487A (en) | Medical composition and its prescription | |
| JPS5551022A (en) | Medicine containing 22*retinilidene**malonic acid derivative*its manufacture and use |